The global spine biologics market is set to grow at a compound annual growth rate of 2.07 percent between 2016 and 2020, according to a Reports Web analysis.
Here are four highlights.
1. Market drivers include a growing geriatric population and an increasing number of spinal disorder cases.
2. Additionally, the growing popularity of minimally invasive surgeries is boosting the development of technologically advanced spinal implants and biologics.
3. The growing number of lumbar fusion procedures will also spur market growth.
4. Key market players include Medtronic, Johnson & Johnson, Stryker, NuVasive, Zimmer Biomet and SeaSpine.